Advanced Filter

Filter by Group

Filter by Market Availability

Clear
Did you mean ly-2216684 of edivoxetine of ly-2216684 of エディボキセチン?
Displaying drugs 101 - 125 of 258 in total

LY-2334737

LY2334737 has been used in trials studying the treatment of Solid Tumor, Metastatic Tumor, and Malignant Solid Tumor.
Investigational
Matched Name: … LY-2334737 …

LY-2300559

Ly2300559 has been used in trials studying the prevention of Migraine Headache.
Investigational
Matched Name: … LY-2300559 …

LY-2811376

LY2811376 has been used in trials studying the basic science of Alzheimer's Disease.
Investigational
Matched Name: … LY-2811376 …

Dansyllysine

Experimental

WT-1 331 long

Investigational

L-homoarginine

Experimental

LY-517717

LY517717 is an investigational oral direct inhibitor of activated Factor Xa. It is believed to be Lilly's PMD-3112 (licensed from Amgen).
Investigational
Matched Name: … LY-517717 …

LY-518674

LY518674 has been used in trials studying the treatment of Metabolic Syndrome X.
Investigational
Matched Name: … LY-518674 …

Lym-1-I-131

Lym-1-I-131 is a monoclonal antibody labeled with iodine-131 (131I) that preferentially targets malignant lymphocytes.
Investigational

Nerinetide

Na 1 is under investigation in clinical trial NCT00728182 (Evaluating Neuroprotection in Aneurysm Coiling Therapy).
Investigational

Iodine I-124 Evuzamitide

Investigational

CTCE-9908

Investigational

LY-2599506

LY2599506 was under investigation in clinical trials NCT01024244 and NCT01029795 for the treatment of patients with type 2 diabetes.
Investigational
Matched Name: … LY-2599506 …

LY-2886721

LY2886721 has been used in trials studying the basic science of Alzheimer's Disease.
Investigational
Matched Name: … LY-2886721 …

LY-2874455

LY2874455 has been used in trials studying the treatment of Advanced Cancer.
Investigational
Matched Name: … LY-2874455 …

LY-2881835

LY-2881835 is under investigation in clinical trial NCT01358981 (A Study of LY2881835 in Healthy People and People With Diabetes).
Investigational
Matched Name: … LY-2881835 …
Matched Description: … LY-2881835 is under investigation in clinical trial NCT01358981 (A Study of LY2881835 in Healthy People …

LY-3200882

LY-3200882 is under investigation in clinical trial NCT04158700 (A Study of LY3200882 and Pembrolizumab in Participants With Advanced Cancer).
Investigational
Matched Name: … LY-3200882 …
Matched Description: … LY-3200882 is under investigation in clinical trial NCT04158700 (A Study of LY3200882 and Pembrolizumab …

LY-2183240

LY-2183240 is an inhibitor of endocannabinoid reuptake/breakdown.
Investigational
Matched Name: … LY-2183240 …
Matched Description: … LY-2183240 is an inhibitor of endocannabinoid reuptake/breakdown.[A253037] …

SOR-C13

SOR-C13 is under investigation in clinical trial NCT01578564 (Safety and Tolerability Study of SOR-C13 in Subjects With Advanced Cancers Commonly Known to Express the TRPV6 Channel).
Investigational

Rusfertide

Rusfertide is a hepcidin mimetic currently being developed by Protagonist Therapeutics for the treatment of polycythemia vera and beta-thalassemia.
Investigational

OM-301

Investigational

LTX-109

LTX-109 has been investigated for the treatment of Atopic Dermatitis, Mild Eczema/Dermatoses, and Gram-positive, Skin Infections.
Investigational

Resolvin E1

Resolvin E1 (RX 10001) is under investigation in clinical trial NCT00941018 (Single and Multiple Ascending Oral Dose Study of Resolvin E1 in Healthy Volunteers).
Investigational

Platelet Lysate

Platelet lysate is an acellular compound composed of platelet proteins while also being void of cellular debris, thus making the lysate rich with growth factors. It is extracted through lysis of the plasma membrane of platelets. Because white cell antigens are low in prepared lysate, there is a minimized likelihood...
Investigational

Vasoactive intestinal peptide

Investigational
Displaying drugs 101 - 125 of 258 in total